2014
First Microbiome Restoration Therapy (MRT) in Singapore performed by Dr. David Ong: AMILI Co-Founder.
About AMILIThe Science Behind Better Gut Health
Your gut is unique - and so is Asia. AMILI is one of the leading microbiome companies in the region, built on the world’s largest multi-ethnic Asian gut microbiome database. We use science made for Asia to create targeted products and services that support better gut health in everyday life.
Our JourneyTheAMILIStory
Tracingourjourneyfromresearchoriginstoregionalimpact
2019
Founding of AMILI.
2020
Launched first Southeast Asia's gut health test and MRT service.
2021
Launched targeted probiotics for multi-ethnic asia.
2022
Raised $10.5M USD Series A.
2023
Introduced Analytics-as-a-service; Brand behind the Brands.
2024
Prototyping of microbial test kits for colorectal cancer.
2025
A*STAR partnership to personalise nutrition with the gut as the cornerstone; Diet-as-a-service offering in 2026.
Expertise United By A Shared Commitment
Our strength lies in the passion and expertise of our team. Our diverse group of professionals brings together world-class experience in healthcare, research, and innovation.
Meet the leaders driving microbiome science forward at the helm:
Our FoundersFounded By Leaders In Microbiome Science
Dr. Jeremy Lim
CEO & CO-FOUNDER
Dr. Christopher Ting
CO-FOUNDER & VICE-CHAIRMAN
Dr. Jonathan Lee
CO-FOUNDER
Dr. David Ong
CO-FOUNDER
Our LeadershipLeadership Driving Real-World Impact
Manu Swarup
CHIEF OPERATING OFFICER
Jit Han Tan
CHIEF GROWTH OFFICER
Our AdvisorsBacked By Decades of Experiences
Professor Dr. Michael Kamm
Associate Professor Dr. Pises Pisespongsa
Adj. Associate Professor Dr. Reuben Wong
May Loh
Associate Professor Lee Yuan Kun
Professor Dr. Jose Sollano
Assistant Professor Dr. Ching JianhongSharingMicrobiomeSciencewiththeworld
StayupdatedwithAMILI'slatestbreakthroughsandmediahighlights.
HelpShapeTheFutureofHealthcareinAsia
ExploreopportunitiestogrowyourcareerwhilemakingameaningfulimpacthereatAMILI